Report
Jesse Redmond

3Q Earnings Preview

MariMed reports 3Q earnings on November 8 after the close. We are hosting an earnings review on X (Twitter) with CEO, Interim CFO, and President Jon Levine on November 9 at 11:00 am ET. Those interested can listen live using this link and it will also be recorded. Q/Q, we are expecting 5.4% revenue growth and a slight contraction in AEBITDA. Maryland should be the most significant driver of the top-line improvement. The state began allowing adult-use sales on July 1. According to BDSA, statewide sales are +126% Q/Q, with a 65% increase in prices and a 61% jump in unit volumes. MariMed has one adult-use store in Annapolis and a 90,000-square-foot cultivation facility in Hagerstown. The company also has a GMP-certified kitchen that allows it to make higher-dose edibles for the medical market. MariMed opened the adult-use Panacea Wellness store in Beverly, Massachusetts on April 25 and a Thrive Wellness medical dispensary in Tiffin, Ohio on June 12. While these opened in 2Q, this is the first quarter with a full contribution. Margins will be affected by increased competition and pricing pressure in Illinois and Massachusetts. While state sales were up Q/Q, this was driven by new stores opening and increases in unit volumes. Prices in Massachusetts declined 7% last quarter. Illinois prices fell 3% last quarter and competition has increased from new social-equity stores and Missouri transitioning to adult-use sales. Construction delays and higher input costs may weigh on margins. MariMed has not been immune to supply chain challenges and slow permitting processes. MariMed opened a new store in Casey Illinois on October 11 and is also close to opening its Illinois processing center. This will allow it to bring back its award-winning Betty’s Eddies edibles line. A craft grow is scheduled to open in early 2024 and this will make MariMed vertically integrated in Illinois. Adult-use sales in Ohio are also a potential boost next year. Finally, former CFO Susan Levine resigned effective October 31, 2023. While the company is searching for a new CFO, current CEO and President Jon Levine is interim CFO. Levine served as CFO from 2017-2022.
Underlying
Provider
Water Tower Research
Water Tower Research

​Water Tower Research is built on the foundation of democratizing information flow. We bridge the growing information gap between companies and investors through our investor engagement strategies and open-access research platform.

Our research analysts are Wall Street veterans with the experience and knowledge to work with companies and investors in tandem. We provide access to the information and content that anchors the due diligence process for both professional money managers and individual investors. We leverage traditional research distribution channels and the best of modern digital strategies and tactics to amplify this information flow globally to engage all categories of investors and stakeholders.

Information flow is the foundation for creating investor awareness, knowledge, and engagement. Our mission is to help companies and investors have the tools they need and achieve their goals.

Analysts
Jesse Redmond

Other Reports on these Companies
Other Reports from Water Tower Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch